BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Startup San Diego - ECPv6.18.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://startupsd.org
X-WR-CALDESC:Events for Startup San Diego
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260128T180000
DTEND;TZID=America/Los_Angeles:20260128T193000
DTSTAMP:20260112T181858Z
CREATED:20260112T181858Z
LAST-MODIFIED:20260112T181858Z
UID:10000926-1769623200-1769628600@startupsd.org
SUMMARY:Nucleate SD: Inside Venture Creation 101
DESCRIPTION:​Join us for an immersive panel on the fundamentals of biotech venture creation. We’re bringing together a panel of serial entrepreneurs\, venture capitalists\, and regulatory strategy experts to deconstruct the journey from ideation to exit. \n​Our experts will dive deep into: \n\n\n​Ideation: Identifying high-impact scientific opportunities. \n\n\n​The Framework: Navigating regulatory pathways and legal hurdles. \n\n\n​The Pitch: Mastering the art of storytelling to win over investors. \n\n\n​Fundraising: Understanding what VCs really look for in a seed-stage startup. \n\n\n​Whether you are a PhD candidate or an undergrad curious about the business of science\, this session will provide the blueprint you need to build the next great biotech venture. Learn more about our panelists below. \nArdy Arianpour: Ardy Arianpour is CEO & Co-Founder of SEQSTER\, the leading healthcare technology company that puts the patient at the center of all their health data. He is a visionary health tech executive with 20+ years driving innovation in life sciences\, pharma and digital health. \n​SEQSTER was founded in 2016 in San Diego with the mission of positively impacting patient lives at scale by removing the barriers to health data access. Prior to starting SEQSTER\, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics\, and served as SVP of Ambry Genetics\, which sold to Konica in 2017 for $1 Billion. \nSandra Pankow: Sandra is the founder and CEO of 3D BioAnalytiX. BioAnalytiX provide innovative tools to help you advance your drug development and structural proteomics research and develop better diagnostic tests to help find cures for devastating diseases faster \n​Chris Mason: Chris Mason is a clinician-scientist with over 30 years of cell and gene therapy experience spanning R&D clinical medicine\, manufacturing\, and commercialization. He is a serial entrepreneur\, including a Founder and CEO of Sun Vectors\, and Founder and Board Director of OriBiotech\, both focused on enabling cell and gene therapy for everyone regardless of geography or financial resources. He was a Founder and former Chief Scientific Officer at Avrobio and Board Director of several companies\, including Krystal Biotech and Papillon Therapeutics. Chris was instrumental in the founding of the industry advocacy group\, the Alliance for Regenerative Medicine \, and is a current Board Director. He is a Full Professor of Cell and Gene Therapy at University College London\, and is the Senior Editor of the journals\, ‘Cell and Gene Therapy Insights’ and ‘Regenerative Medicine’. \n​About the Host:​ \n​​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions\, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming\, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information\, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy. \n​​We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs! \n​​Platinum: Eli Lilly and Company\, Genentech\, Alnylam Pharmaceuticals\, MilliporeSigma \n​​Philanthropic Support: Lyda Hill Philanthropies \n​​Preferred Partners: Pillar VC\, Amino Collective\, Excedr\, Mercury\, Brex\, Fedsprout \n​​In-Kind Support: AcademicLabs\, Lens.org\, SynBioBeta
URL:https://startupsd.org/event/nucleate-sd-inside-venture-creation-101/
LOCATION:Tata Hall\, 9325 S Scholars Dr\, La Jolla\, CA\, 92093\, United States
CATEGORIES:Ecosystem
ATTACH;FMTTYPE=image/jpeg:https://startupsd.org/wp-content/uploads/2026/01/Nucleate-SD-Inside-Venture-Creation-101-.jpeg
END:VEVENT
END:VCALENDAR